Search Database

Name

IPI-504

Alternate Names

IPI-504
Retaspimycin hydrochloride

Abbreviations

None

Category

Chemotherapy

Subcategory

HPS90 inhibitor
Molecular inhibitor

NSC Number

None

Primary Site

breast
GIST
lung
melanoma
Myeloma
prostate
soft tissue
solid tumor

Histology

None

Remarks

Currently in phase II and III trials for NCSLC and phase III trial for GIST (RING trial). Code as other therapy until FDA approval.

Coding

This drug should be coded
Glossary